Neuralink is a privately held company. This means only accredited and institutional investors can invest in the company before its IPO. Investors seeking exposure to Neuralink can invest indirectly via venture funds and investment syndicates, or purchase shares directly on pre-IPO marketplaces like Hiive.

Due to regulations, only accredited and institutional investors are eligible to purchase highly illiquid assets such as private company stock. In most cases, whether you can buy Neuralink shares is also ultimately subject to the company's decision to exercise its right of first refusal and final approval.

For more details on the process, read our guide on investing in pre-IPO companies.

If you own Neuralink shares, you may be able to find a buyer on pre-IPO marketplaces or via an introduction by a registered broker. Your ability to sell your shares ultimately depends on several factors such as the class of shares you own, the holding period prescribed by regulations, if applicable, and Neuralink's stance on share transfers as laid out in option agreements, option plans, company bylaws, shareholder agreements, or other company documents.

Want to learn more? Read this guide to selling pre-IPO shares and frequently asked questions.

As a privately held company, Neuralink has no public stock price. To access current and historical pricing information on Neuralink stock, you can review filings from the company's past primary funding rounds, fund marks, and information from secondary trading data providers. Hiive also offers free access to historical trading data on hundreds of the top pre-IPO companies such as Neuralink.

The valuation of private companies such as Neuralink is not readily available because they are not listed on public exchanges.

One source of information on Neuralink's valuation is the details of its most recent primary funding rounds. Financial and technology news sources such as Reuters, Bloomberg, Techcrunch, and The Information routinely report on private company funding rounds and can be a good source of information. Alternatively, you can look at Neuralink's official website for releases and investor relations updates, alongside venture capital databases such as Crunchbase, Pitchbook, and Preqin.

Neuralink remains a privately held company and cannot be accessed on major public exchanges such as NASDAQ or NYSE.

Accredited investors can invest in the top private companies like Neuralink before they IPO via secondary marketplaces such as Hiive.